Talaris Therapeutics Buy Hold or Sell Recommendation
| TALSDelisted Stock | USD 2.98 0.10 3.25% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Talaris Therapeutics is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Talaris Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Talaris Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. Note, we conduct extensive research on individual companies such as Talaris and provide practical buy, sell, or hold advice based on investors' constraints. Talaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Talaris |
Execute Talaris Therapeutics Buy or Sell Advice
The Talaris recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Talaris Therapeutics. Macroaxis does not own or have any residual interests in Talaris Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Talaris Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Talaris Therapeutics Trading Alerts and Improvement Suggestions
| Talaris Therapeutics is not yet fully synchronised with the market data | |
| Talaris Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (73.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Talaris Therapeutics currently holds about 207.11 M in cash with (60.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 78.0% of the company shares are owned by institutional investors |
Talaris Therapeutics Returns Distribution Density
The distribution of Talaris Therapeutics' historical returns is an attempt to chart the uncertainty of Talaris Therapeutics' future price movements. The chart of the probability distribution of Talaris Therapeutics daily returns describes the distribution of returns around its average expected value. We use Talaris Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Talaris Therapeutics returns is essential to provide solid investment advice for Talaris Therapeutics.
| Mean Return | 0.57 | Value At Risk | -5.95 | Potential Upside | 7.32 | Standard Deviation | 4.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Talaris Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Payment of 11786 shares by Requadt Scott of Talaris Therapeutics subject to Rule 16b-3 [view details]
Talaris Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Talaris . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Talaris Therapeutics Buy or Sell Advice
When is the right time to buy or sell Talaris Therapeutics? Buying financial instruments such as Talaris Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Talaris Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |